Kawasaki disease
Conditions
Interventions
None listed
Sponsors
Tokyo Metropolitan Children's Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients diagnosed with Kawasaki disease Subjects who agreed, or whose parents provided consent for enrollment in the study
Exclusion criteria
Exclusion criteria: Subjects without stool sample Patients considered inappropriate for enrollment by investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of Yersinia infection among patients diagnosed with Kawasaki disease | — |
Secondary
| Measure | Time frame |
|---|---|
| The difference in the following characteristics between Yersinia positive patients and negative patients: duration of fever, unresponsiveness to IVIG, coronary artery lesion within 2 months from the beginning of treatment | — |
Countries
Japan
Contacts
Public ContactHiroshi Hayashi
Tokyo Metropolitan Children's Medical Center Department of General Pediatrics
Outcome results
None listed